×
ADVERTISEMENT

Triumeq

FDA Warns of Neural Tube Birth Defects With Dolutegravir

The FDA issued an alert about serious cases of neural tube birth defects involving the brain, spine and spinal cord ...

MAY 18, 2018

Switching HIV Regimen Found Safe

Switching to the newly approved Biktarvy in virologically suppressed adults maintained viral suppression with fewer ...

MARCH 7, 2018

Bictegravir-Containing Compound Found Noninferior in Phase 3 Trial

Bictegravir is a novel, potent integrase strand transfer inhibitor (INSTI), which features a high in vitro barrier ...

OCTOBER 10, 2017

Load more